COMMUNIQUÉS West-GlobeNewswire

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
04/08/2026
BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine [...]
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 2026 Financial Results
04/08/2026
Advancing a neuromuscular franchise with claseprubart, a highly potent investigational classical pathway inhibitor, with best-in-disease potential across generalized Myasthenia Gravis (gMG), Chronic Inflammatory [...]
Pacira BioSciences Reports Second Quarter 2026 Financial Results
04/08/2026
-- Continued execution of 5x30 strategy marked by solid revenue growth, durable cashflows, advancing pipeline, and high-caliber commercial partnerships -- -- Delivered second quarter total revenue of $192.4 million, [...]
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/08/2026
BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced that [...]
Milestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026
04/08/2026
MONTREAL and CHARLOTTE, N.C., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular [...]
Syndax Reports Second Quarter 2026 Financial Results and Provides Business Update
04/08/2026
– Total revenue of $73 million in 2Q26, a 92% year-over-year increase – – Revuforj ® (revumenib) net revenue of $54.7 million in 2Q26, a 91% year-over-year increase – – Niktimvo™ (axatilimab-csfr) net revenue of $60.3 [...]
Spero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026
04/08/2026
CAMBRIDGE, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on advancing next-generation medicines in immunology and inflammation, [...]
Acquisition of Own Shares
04/08/2026
Mechelen, Belgium; 04 August 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") [...]
Applied Biologics Marks 10 Years of Continuous AATB Accreditation While Initiating Reaccreditation Process
04/08/2026
Company continues its longstanding commitment to quality, safety, and regulatory excellence supporting the manufacture and distribution of XWRAP® SCOTTSDALE, Ariz., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a [...]
Pennant Acquires River Centre Assisted Living in Tucson, Arizona
04/08/2026
EAGLE, Idaho, Aug. 04, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of Pennant affiliated home health, hospice, home care and senior living companies, announces today that [...]
Taysha Gene Therapies to Release Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 11
04/08/2026
DALLAS, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies [...]
FSR Invests $700,000 Across Four Sarcoidosis Studies to Improve Diagnosis, Monitoring, and Patient Outcomes
04/08/2026
CHICAGO, Aug. 04, 2026 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) has awarded $700,000 in grant funding to four awardees through its Early Career Fellowship and Established Investigator grant [...]
ClinNEXUS Appoints John Stamatopoulos to New Position of Chief Growth Officer
04/08/2026
- Seasoned digital health growth executive with demonstrated ability to build revenue and drive disciplined expansion - LOS ANGELES, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ClinNEXUS, a data-driven healthcare company that’s [...]
Novo Nordisk reports adjusted operating profit of DKK 33,389 million for Q2 2026 and raises full-year outlook
04/08/2026
Bagsværd, 4 August 2026 - Financial report for the period 1 January 2026 to 30 June 2026 Financial performance Q2 2026 reported sales increased by 3% at CER, with growth negatively impacted by a DKK 2.6 billion rebate [...]
Novo Nordisk raises adjusted sales and adjusted operating profit outlook for 2026
04/08/2026
Bagsværd, Denmark, 4 August 2026 – Novo Nordisk today announced adjusted sales and adjusted operating profit for the second quarter of 2026 and raised 2026 full-year adjusted sales and adjusted operating profit outlook [...]
Zelluna ASA: Disclosure of large shareholding
04/08/2026
Reference is made to the stock exchange announcement published by Zelluna ASA (the "Company") on 4 August 2026 regarding the issuance of 446,752 new shares to Inven2 AS. Inven2 AS currently holds 1,439,325 shares in the [...]
Dr. Naved Fatmi Expands Leadership in Healthcare, Education, and Community Service with Appointment to Palm Beach State College Foundation Board
04/08/2026
BOCA RATON, Florida, Aug. 04, 2026 (GLOBE NEWSWIRE) -- BOCA RATON, Fla. — August 1, 2026 — Dr. Naved Fatmi, DMD , a Florida-based dental entrepreneur, educator, and former Chairman of the Florida Board of Dentistry, is [...]
Zelluna ASA: Issuance of shares to Inven2 through set-off of settlement amounts under option and license agreement
04/08/2026
Oslo, 4 August 2026: Reference is made to the resolution by the Annual General Meeting of Zelluna ASA (the "Company") held on 23 April 2026, authorising the Company's Board of Directors to increase the share capital by [...]
EmblemHealth and NewYork-Presbyterian Reach New Agreement
04/08/2026
The new agreement avoids disruption of service while providing access to world-class care. NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- EmblemHealth announced today that it has reached an agreement with NewYork- [...]

Pages